US3072532A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Administration of enzymic composition
Assignee: Individual
•
Filing: 1958-11-04
•
Granted: 1963-01-08
•
Expires: 1978-11-04
Abstract
No abstract record available.
Inventors
- 👤 Innerfield Irving
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 04:26
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/006; A61K38/00; A61K38/16; A61K38/43; A61K38/46; A61K38/48; A61K38/482; A61K38/4826; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/832; Y10S435/839; Y10S435/911; Y10S435/913; Y10S435/917
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
55 words
THE METHOD OF INTRODUCING A THERAPEUTICALLY ACTIVE ENZYMIC MATERIAL INTO THE SYSTEMIC CIRCULATION OF SUBJECT WHICH COMPRISING PLACING A DOSAGE QUANTITY OF A PROTEASE IN CONTACT WITH MUCOUS MEMBRANCE AND MAINTAINING THE PROTEASE IN CONTACT WITH SAID MEMBRANE IN THE PRESENCE OF BODY FLUID UNTIL SAID THERAPEUTICALLY ACTIVE ENZYMIC MATERIAL IS ABSORBED BY SAID SUBJECT.
Claim 2
Independent Claim
55 words
THE METHOD OF INTRODUCING A THERAPEUTICALLY ACTIVE ENZYMIC MATERIAL INTO THE SYSTEMIC CIRCULATION OF SUBJECT WHICH COMPRISING PLACING A DOSAGE QUANTITY OF A PROTEASE IN CONTACT WITH MUCOUS MEMBRANCE AND MAINTAINING THE PROTEASE IN CONTACT WITH SAID MEMBRANE IN THE PRESENCE OF BODY FLUID UNTIL SAID THERAPEUTICALLY ACTIVE ENZYMIC MATERIAL IS ABSORBED BY SAID SUBJECT.
References Cited (Backward Citations)
US2527686A
Cited
US3019167A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1966-01-07 | 1966-07-09 | 1967-01-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1970-01-07 | 1970-07-09 | 1971-01-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1974-01-07 | 1974-07-09 | 1975-01-08 | $7700.00 | Window Closed / Lapsed |